Metraipolis › archive › dc_365ebae81be2

Characterizing industry payments for FDA-approved AI medical devices — Europe PMC PMID:41357259

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41357259
DOI
10.1093/haschl/qxaf211
License (as archived)
solo-consultazione
Archived
2026-11-08T16:36:42.453Z
SHA-256 of the archived text
f4ca17c7acad72b37cc13da7ad0ba6a8efa015ab1075f2087198e2b88adac4d0
Stable URL of this page
https://metraipolis.com/documento/dc_365ebae81be2

How to cite

Characterizing industry payments for FDA-approved AI medical devices — Europe PMC PMID:41357259 — Europe PMC (en), https://europepmc.org/article/MED/41357259 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_365ebae81be2 (Metraipolis archive dc_365ebae81be2, sha256 f4ca17c7acad72b37cc13da7ad0ba6a8efa015ab1075f2087198e2b88adac4d0)
BibTeX
@misc{dc365ebae81be2,
  title = {Characterizing industry payments for FDA-approved AI medical devices — Europe PMC PMID:41357259},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41357259},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_365ebae81be2; sha256 f4ca17c7acad72b37cc13da7ad0ba6a8efa015ab1075f2087198e2b88adac4d0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41357259. Agents can read the archived copy with the MCP tool read_document.